We are live on ! Find out more

20 hedge funds and large institutions have $1.76M invested in Imunon in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more capital invested

Capital invested by funds: $879K → $1.76M (+$883K)

18% more funds holding

Funds holding: 1720 (+3)

7.62% more ownership

Funds ownership: 6.45%14.07% (+7.6%)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Holders
20
Holders Change
+3
Holders Change %
+17.65%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
6
Closed
Calls
Puts
Net Calls
Net Calls Change

IMNN Hedge Fund Activity: Q4 2025 in Review

20 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q4 2025, worth a combined $1.76M — up 101% from $879K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new IMNN positions and 0 closed out — a net gain of 3 holders — while 4 added to existing stakes and 6 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $1.14M. The largest seller was UBS Group, cutting an estimated $39.4K.

  • 20 institutional investors held Imunon (IMNN) as of Q4 2025, up from 17 in Q3 2025.
  • Funds reported $1.76M of Imunon stock for Q4 2025, up 101% quarter-over-quarter.
  • 3 funds opened new Imunon positions in Q4 2025 and 0 closed out, a net change of +3 holders.
  • The largest Imunon buyer in Q4 2025 was Armistice Capital, an estimated $1.14M added.
  • The largest Imunon seller in Q4 2025 was UBS Group, an estimated $39.4K sold.

Based on aggregated 13F filings for Q4 2025.